Niemann-Pick Disease, A Pipeline Analysis Report 2018

Technavio has published a new report on the drug development pipeline for Niemann-pick disease, including a study of the pipeline molecules.

Rapid Diagnosis of 83 Patients with Niemann Pick Type C Disease and Related Cholesterol Transport Disorders by Cholestantriol Screening - eBioMedicine

Investigation of Brain Iron in Niemann-Pick Type C: A 7T Quantitative Susceptibility Mapping Study

CD164 is a host factor for lymphocytic choriomeningitis virus entry

Niemann-Pick disease - Breda Genetics srl Breda Genetics srl

Biomolecules, Free Full-Text

Frontiers Reconstruction of the Cytokine Signaling in Lysosomal Storage Diseases by Literature Mining and Network Analysis

F-1/A

Human acid sphingomyelinase structures provide insight to molecular basis of Niemann–Pick disease

5 Most Promising Companies offering hope to patients with Niemann-Pick Type C

The GUaRDIAN framework. Clinicians refer patients and family members to

New Therapeutic Approaches to Inherited Metabolic Pediatric Epilepsies

Niemann-Pick-Disease Pipeline, FDA Approvals, Clinical

IPO Launch: Orphazyme A/S Finalizes Terms For $100 Million U.S. IPO - IPOs On TheStreet - U.S. IPO Research & Opinion

Magellan Rx Report - Spring 2023 by Magellan Rx Management - Issuu

Niemann-Pick Disease Market to grow at a CAGR of over 5.2% from